PetVivo Holdings, Inc. to Present at Sequire Virtual Small Cap Conference on December 8th, 2022
December 05, 2022 11:25 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, Dec. 05, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the "Company") an emerging biomedical device company focused on the commercialization of...
PetVivo Reports Second Quarter of Fiscal 2023 Financial Results
November 10, 2022 16:00 ET
|
PetVivo Holdings, Inc.
Conference call begins at 4:00 p.m. Central time today EDINA, MN, Nov. 10, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (“PetVivo” or the “Company”) (Nasdaq: PETV), an emerging...
PetVivo Holdings, Inc. to Exhibit at American Association of Equine Practitioners Conference in San Antonio, Texas
November 09, 2022 08:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Nov. 09, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV, PETVW) (the "Company") an emerging biomedical device company focused on the commercialization of...
Sorrento Therapeutics Completes Enrollment of Phase 2 Clinical Trial of Resiniferatoxin (RTX) for Treatment of Knee Pain in Moderate to Severe Osteoarthritis of the Knee (OAK) Patients
September 26, 2022 09:00 ET
|
Sorrento Therapeutics, Inc.
Phase 2 trial of RTX for OAK pain completed enrollment with last patient (n=120) dosedNo limiting toxicities have been encountered during the trial to date. Patients are now being monitored for...
Viscosupplementation Market Is Expected to Reach USD 10.9 Billion by 2031: Says Allied Market Research
September 22, 2022 09:05 ET
|
Allied Market Research
Portland, OR, Sept. 22, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global viscosupplementation market was estimated at $4.4 billion in 2021 and is...
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AMPE
August 19, 2022 10:51 ET
|
The Rosen Law Firm PA
NEW YORK, Aug. 19, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of...
CELLS for CELLS treats the first-ever patient with an exosome-produced therapy for osteoarthritis
July 18, 2022 15:54 ET
|
Cells for Cells
SAN FRANCISCO, July 18, 2022 (GLOBE NEWSWIRE) -- Cells for Cells ("C4C"), a clinical-stage biotech pioneering allogeneic stem cell and stem-cells-derived therapeutics for high-impact chronic...
ECCO Medical Brings Pain-Relieving Knee Embolization Treatment to Denver Area
June 15, 2022 08:00 ET
|
ECCO Medical
LONE TREE, Colo., June 15, 2022 (GLOBE NEWSWIRE) -- ECCO Medical, a Denver-based interventional radiology clinic, has begun evaluating patients and performing an innovative outpatient embolization...
PetVivo, makers of Spryng™ with OsteoCushion™ Technology, introduces new Q&A sessions with equine expert Dr. Tracy Turner
June 01, 2022 13:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, June 01, 2022 (GLOBE NEWSWIRE) -- PetVivo, the company who makes SpryngTM with OsteoCushionTM Technology, is proud to work in collaboration with Dr. Tracy Turner, a recognized expert in...
Ocugen Announces New Cell Therapy Program Following FDA Regenerative Medicine Advanced Therapy (RMAT) Recognition
May 24, 2022 07:11 ET
|
Ocugen
NeoCart® (autologous chondrocyte-derived neocartilage) receives regulatory designation intended to help expedite development of new regenerative medicines MALVERN, Pa., May 24, 2022 (GLOBE...